本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

334.58
-3.9900-1.18%
盤前334.00-0.5800-0.17%07:00 EDT
成交量:17.54萬
成交額:5,938.70萬
市值:93.18億
市盈率:-26.01
高:348.00
開:340.00
低:334.00
收:338.57
52周最高:392.70
52周最低:37.25
股本:2,785.08萬
流通股本:2,407.65萬
量比:0.71
換手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-12.8634
每股收益(LYR):-13.4758
淨資產收益率:-38.86%
總資產收益率:-25.65%
市淨率:6.95
市盈率(LYR):-24.83

資料載入中...

2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/01

重要事件披露

8-K - Current report
2020/11/23

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/17

重要事件披露

8-K - Current report
2020/11/10

重要事件披露

8-K - Current report
2020/10/20

重要事件披露

8-K - Current report
2020/10/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/15

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933